Nov 07, 2022
Ukrainian pharmaceutical manufacturers continue to launch new medicines on the market, despite the active hostilities in the country

Despite the war, Ukraine's largest pharmaceutical company, Farmak, opened a new site for the production of medicines in nebulas and launched 11 new products on the market. These are medicines for the treatment of respiratory tract and bronchial asthma, thrombosis and acute myocardial infarction, as well as radiopaque, anti-inflammatory, painkillers and vitamins for children. In addition, in the 4th quarter of 2022, the company plans to launch 6 more new medicines on the market.

"Our company is not only a leader in the production and export of pharmaceutical products, but also the largest taxpayer in the industry. Therefore, today we are facing two important tasks at once: to provide Ukrainians with high-quality medicine and to fill the state budget with taxes. And we do it. Moreover, on February 28, in the midst of the war, we paid taxes in advance, realizing how important business support is for the state," said Volodymyr Kostiuk, CEO of Farmak.

Currently, the company's product portfolio includes more than 400 types of medicines. The key therapeutic groups include flu, endocrinology, gastroenterology, cardiology, and the nervous system. Farmak annually reinvests up to 90% of its profits in development. Over the past 20 years, the amount of investments in the development of the enterprise has amounted to more than 400 million US dollars. The Company's annual investment in research and development is approximately US$15 million. The production facilities of Farmak and its R&D complex are internationally certified and meet the high requirements of European GMP standards.

Back to the News
Previous
More news
Clinic on wheels: how to get a free examination and get...

In October, the volunteers of the DyvoUA Charitable Foundation launched the Mobile Doctors project, within the framework of which they conduct free medical examinations of people in the territories liberated from the aggressor. In addition to high-quality diagnostics and medical advice, Ukrainians can also receive the necessary medicines free of charge, whic...

Oct 18, 2022
The story of Farmak was included in the UN study as a c...

Every year in September, a meeting of the UN General Assembly is held, where the first persons of the world discuss the main challenges. This time the meeting was attended by representatives of all 193 member countries. One of the main issues was the Russian invasion of Ukraine. During the event, they also talked about […]

Oct 05, 2022
Two Farmak projects at once became winners in the prest...

The victories from the "past life" are catching up with us today. In pre-war February, the marketing project competition X-RAY Marketing Awards from Marketing Media Review started. The Committee stopped online and expert voting for the contest nominees on February 24 with the start of a full-scale war, but resumed it in September. More than [&hel...

Sep 30, 2022

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Farmak PAT published this content on 07 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 November 2022 13:53:03 UTC.